Skip to content

Cancer Genetics & Molecular Oncology

Clinician referral required

AML Extended Panel

Tests for t(15;17), t(8;21), inv(16), NPM1, FLT3-ITD, FLT3-TKD, IDH1, IDH2 and TP53 in acute myeloid leukaemia.

Test code:

  • Sample

    Bone marrow or blood

  • Method

    NGS and PCR

  • Turnaround

    21 days

About this test

Tests for t(15;17), t(8;21), inv(16), NPM1, FLT3-ITD, FLT3-TKD, IDH1, IDH2 and TP53 in acute myeloid leukaemia.

Screens forAcute myeloid leukaemia

Yes, a doctor's referral is required for this test.

No special preparation is usually required; confirm specimen-specific instructions with the laboratory.

Samples can only be collected by your clinician.

The results indicate whether the tested genetic mutations and chromosomal abnormalities are detected or not detected, including their specific findings where applicable. Discuss the results with your doctor before making any decisions.

Need help?

Not sure this is the right test?

Our team can help you or your clinician find the right pathway.